Patent Assignment
Reel/Frame 069384/0892
Change of Assignee Address
Recorded: 2024-08-19
Pages: 3
Assignor
AGOMAB THERAPEUTICS
Executed: 2024-08-19
Assignee
AGOMAB THERAPEUTICS
POSTHOFLEI 1 / 6, BERCHEM, 2600, BELGIUM
Covered Properties
(4)
Anti-Met Antibodies and Uses Thereof
Anti-Met Antibodies and Uses Thereof
Application:
18/538,107 →
Publication:
US 2024/0228632
Anti-Met Antibodies and Uses Thereof
Anti-Met Agonist Antibody for Use in the Treatment of Colorectal Cancer
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Combined Declaration and Assignment
Mar 1, 2019
From: MICHIELI, PAOLO
To: AGOMAB THERAPEUTICS BVBA
Reel/Frame 048478/0682 →
Combined Oath and Assignment
Jul 14, 2020
From: MICHIELI, PAOLO
To: AGOMAB THERAPEUTICS
Reel/Frame 053201/0036 →
Assignment of Assignor's Interest
Aug 9, 2021
From: MICHIELI, PAOLO
To: AGOMAB THERAPEUTICS BVBA
Reel/Frame 057124/0319 →
Change of Name
Jul 25, 2022
From: AGOMAB THERAPEUTICS BVBA
To: AGOMAB THERAPEUTICS
Reel/Frame 060855/0961 →
Corrective Assignment to Correct the Receiving Party Data to Agomab Therapeutics, Franklin Rooseveltlaan 348,9000 Gent Belgium Previously Recorded at Reel: 057124 Frame: 0139. Assignor(S) Hereby Confirms the Assignment.
Nov 6, 2023
From: MICHIELI, PAOLO
To: AGOMAB THERAPEUTICS
Reel/Frame 065473/0015 →
Assignment of Assignor's Interest
Jan 31, 2024
From: MICHIELI, PAOLO
To: AGOMAB THERAPEUTICS BVBA
Reel/Frame 066313/0268 →
Corrective Assignment to Correct the Receiving Party Name Previously Recorded at Reel: 66313 Frame: 268. Assignor(S) Hereby Confirms the Assignment.
Mar 22, 2024
From: MICHIELI, PAOLO
To: AGOMAB THERAPEUTICS
Reel/Frame 066873/0883 →